Clinical Trials Logo

Pathogenesis clinical trials

View clinical trials related to Pathogenesis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05881616 Recruiting - Diagnosis Clinical Trials

Study on Serum Metabolomics of GDM

Start date: July 18, 2023
Phase:
Study type: Observational [Patient Registry]

This study aims to collect serum samples from healthy non-pregnant women, pregnant women with and without Gestational Diabetes Mellitus (GDM). We will analyze the metabolite changes among the three groups using clinical metabolomics and identify potential biomarkers and metabolic pathways. This study will provide scientific evidence for early clinical diagnosis, prevention, control, and treatment research of GDM.

NCT ID: NCT05682001 Recruiting - Cataract Clinical Trials

The Molecular Pathogenesis Study of Cataract

Start date: January 1, 2022
Phase:
Study type: Observational

To study the molecular pathogenesis of cataract and explore possible treatments,anterior lens capsules were collected from cataract patients

NCT ID: NCT03557047 Recruiting - Acute Kidney Injury Clinical Trials

Perioperative Mechanism of Acute Kidney Injury in Cardiovascular Surgery

Start date: March 8, 2018
Phase:
Study type: Observational [Patient Registry]

Continuous observation of acute renal injury after cardiac surgery, at the same time retention of blood samples, to test indicators,and to select the research route from the clinical actual test results .

NCT ID: NCT01425892 Recruiting - Sjogren's Syndrome Clinical Trials

The Pathogenesis and Natural History of Sjogren's Disease

Start date: January 18, 2012
Phase:
Study type: Observational

Background: -Sjogren s Disease is a disease that affects about 1-4 million Americans. It is more common in women. It mainly affects the glands that produce saliva and tears, leading to dry eyes and dry mouth. The cause of Sjogren s Disease is unknown, but inflammation plays an important role. The purpose of this study is to learn more about Sjogren s Disease. Objectives: -To better understand how Sjogren s Disease begins and how it affects patients so that we can develop better ways to treat them. Eligibility: - Participants must be 16 years of age or older. - They must have a diagnosis of Sjogren s Disease or have at least two symptoms of Sjogren s Disease. Design: - People taking part in the study will come to the NIH Clinical Center for at least three visits. - During these visits, participants will have a medical history and physical exam. They will have oral and dental assessments, and saliva collection. Lab tests (blood and urine) and dry eye exams will be done. Participants will answer questionnaires and have salivary scintigraphy (adults only unless required for diagnosis). - Other optional tests may also be done. Participants may have to come in for additional visits if they have these optional tests or if their disease changes. - The only treatment provided as part of this study is for medical emergencies or complications that occur while you are at NIH for evaluation.